Empagliflozin

Details

Files
Generic Name:
Empagliflozin
Project Status:
Complete
Therapeutic Area:
Diabetes mellitus, type 2 with high cardiovascular risk
Manufacturer:
Boehringer Ingelheim (Canada) Ltd.
Call for patient/clinician input open:
Brand Name:
Jardiance
Project Line:
Reimbursement Review
Project Number:
SR0488-000
Call for patient/clinician input closed:
NOC Status at Filing:
Pre NOC
Performance Metric:
Achieved
Submission Type:
Initial
Indications:
Diabetes mellitus, type 2 with high cardiovascular risk
Recommendation Type:
Reimburse with clinical criteria and/or conditions
Final Recommendation: